Stride vs BeatO
BeatO is India's largest virtual diabetes-care platform — 10 years in market, 2 million+ users, 2.5 million app downloads, government-recognized, ADA-published. Stride is a focused, doctor-led GLP-1 weight management platform, purpose-built for medication-led sustainable weight loss. They overlap on the metabolic-health spectrum but serve very different patient needs.
Stride is built for one outcome: doctor-prescribed, continuously monitored medical weight loss using GLP-1 medications (Wegovy, Mounjaro, Yurpeak, generic semaglutide). One fixed price (₹9,999 for the 3-Month Early Edition) bundles assessment, at-home blood test, doctor video consultations, monthly medication delivery, nutrition support, and continuous care-team availability.
BeatO is India's largest diabetes-care platform — virtual glucose monitoring, in-house glucometer (BeatO CURV), 40+ health coaches, supplements + foods + lifestyle products marketplace, optional Care Health Insurance bundling. No GLP-1 medication offering as of mid-2026.
Side-by-side
| Stride | BeatO | |
|---|---|---|
| Primary focus | GLP-1-led medical weight management | Diabetes care + glucose monitoring |
| GLP-1 medications | Yes — Wegovy / Mounjaro / generic semaglutide when prescribed | Not offered |
| Care model | Doctor-led (licensed clinicians) | Coach-led (40+ in-house health coaches) |
| Hardware | None — pure telehealth | Proprietary BeatO CURV glucometer + Abbott Libre CGM |
| Pricing | ₹9,999 fixed for 3 months — transparent | Subscription tiers — pricing varies, not published openly |
| Blood test | At-home, included | Lab tests at up to 75% off (separate purchase) |
| Doctor consultations | Included; care team available throughout | Unlimited specialist consultations in plans |
| Auto-renewal | No — one-time payment | Subscription-based |
| Insurance | Not currently bundled | Optional Care Health Insurance up to ₹5L |
| Geographic coverage | Pan-India remote | Pan-India, app + shop ecosystem |
| Best fit | Adults seeking medical weight management with GLP-1 | Existing diabetics wanting end-to-end diabetes care |
Who each is for
Adults with BMI ≥27 (with comorbidities) or ≥30, seeking doctor-led, medication-supported weight management. The right fit if your primary goal is sustainable weight loss and you're open to GLP-1 medications when clinically appropriate.
People with diagnosed type 2 diabetes who want comprehensive diabetes management — glucose tracking, coach-led behaviour change, supplements, and the broader BeatO product ecosystem. The right fit if blood-sugar control is your primary concern.
Honest verdict
These aren't really competitors — they're adjacent. BeatO is excellent for what it does: diabetes management at scale, with a strong coach-led behaviour change model and proprietary hardware. Stride is built for the specific use case BeatO doesn't address: medication-led, doctor-monitored weight management with GLP-1s. If you're a BeatO user managing diabetes and you've been told you'd benefit from GLP-1-driven weight loss, Stride is the structured medical complement BeatO doesn't currently offer.
3-Month Early Edition: ₹9,999
Regular ₹23,999. One-time payment, no auto-renewal. Includes assessment, blood test, doctor consultations, GLP-1 delivery (when prescribed), and nutrition support.
Check Your Eligibility →